Arthritis drug tocilizumab cuts deaths from Covid

116912065 wendycoleman

Prof Martin Landray, joint chief investigator of the RECOVERY trial and a medical professional at Oxford University, mentioned: “Used in combination, the impact is substantial. This is good news for patients and good news for the health services that care for them in the UK and around the world.”